Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-29

FDA Approved: ALMOTRIPTAN MALATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Almotriptan Malate (Teva Pharmaceuticals USA, Inc.), granting regulatory approval for this generic product. The appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Almotriptan malate (almotriptan)

Snippet

SUPPL AP for ALMOTRIPTAN MALATE (ALMOTRIPTAN MALATE)